JP2023520916A5 - - Google Patents
Info
- Publication number
- JP2023520916A5 JP2023520916A5 JP2022561080A JP2022561080A JP2023520916A5 JP 2023520916 A5 JP2023520916 A5 JP 2023520916A5 JP 2022561080 A JP2022561080 A JP 2022561080A JP 2022561080 A JP2022561080 A JP 2022561080A JP 2023520916 A5 JP2023520916 A5 JP 2023520916A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- heteroaryl
- alkyl
- compound
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063007331P | 2020-04-08 | 2020-04-08 | |
| US63/007,331 | 2020-04-08 | ||
| US202063044318P | 2020-06-25 | 2020-06-25 | |
| US63/044,318 | 2020-06-25 | ||
| US202063072922P | 2020-08-31 | 2020-08-31 | |
| US63/072,922 | 2020-08-31 | ||
| US202063126494P | 2020-12-16 | 2020-12-16 | |
| US63/126,494 | 2020-12-16 | ||
| PCT/US2021/026481 WO2021207554A1 (en) | 2020-04-08 | 2021-04-08 | Compounds and methods for modulating splicing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520916A JP2023520916A (ja) | 2023-05-22 |
| JP2023520916A5 true JP2023520916A5 (cg-RX-API-DMAC7.html) | 2024-04-19 |
| JP7879597B2 JP7879597B2 (ja) | 2026-06-24 |
Family
ID=75690721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561080A Active JP7879597B2 (ja) | 2020-04-08 | 2021-04-08 | スプライシングを調整するための化合物及び方法 |
Country Status (15)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| WO2020163248A1 (en) | 2019-02-04 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| WO2020163541A1 (en) | 2019-02-05 | 2020-08-13 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
| JP7603594B2 (ja) | 2019-02-06 | 2024-12-20 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| IL297963A (en) | 2020-05-07 | 2023-01-01 | Adorx Therapeutics Ltd | Antagonists of the adenosine a2a receptor |
| WO2021231571A1 (en) | 2020-05-13 | 2021-11-18 | Chdi Foundation, Inc. | Htt modulators for treating huntington's disease |
| WO2022047145A1 (en) | 2020-08-28 | 2022-03-03 | Arvinas Operations, Inc. | Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use |
| US20250332173A1 (en) * | 2021-10-13 | 2025-10-30 | Remix Therapeutics Inc. | Compounds and methods for modulating nucleic acid splicing |
| AU2022394333A1 (en) | 2021-11-17 | 2024-06-27 | Chdi Foundation, Inc. | HTT modulators for treating Huntington’s disease |
| JP2024541481A (ja) * | 2021-11-24 | 2024-11-08 | リミックス セラピューティクス インコーポレイテッド | スプライシングを調整するための化合物及び方法 |
| US20250326748A1 (en) * | 2022-01-05 | 2025-10-23 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| EP4584258A1 (en) | 2022-09-07 | 2025-07-16 | Arvinas Operations, Inc. | Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use |
| CN116377059B (zh) * | 2023-04-28 | 2026-05-15 | 华中科技大学同济医学院附属协和医院 | Luc7l2在诊断和治疗急性肾损伤中的用途 |
| WO2024259017A1 (en) * | 2023-06-12 | 2024-12-19 | Remix Therapeutics Inc. | Compounds and methods for modulating splicing |
| CN120388720B (zh) * | 2024-09-18 | 2026-02-17 | 大连医科大学附属第二医院 | 基于uqcc2与mettl3的计算机辅助筛选药物的方法、系统和设备 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0309765A3 (en) * | 1987-09-30 | 1990-09-26 | Fisons Corporation | 1(2h)-phthalazinones as cytoprotective agents |
| DE60010448T2 (de) * | 1999-03-17 | 2005-04-07 | Astrazeneca Ab | Amid-derivate |
| GB0324790D0 (en) * | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
| TWI320783B (en) * | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| US20090069300A1 (en) * | 2007-09-12 | 2009-03-12 | Wyeth | Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| UA111579C2 (uk) * | 2009-08-17 | 2016-05-25 | Інтеллікіне Ллк | ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ |
| EP3406252B1 (en) | 2012-02-10 | 2020-05-13 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| US8729263B2 (en) | 2012-08-13 | 2014-05-20 | Novartis Ag | 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions |
| HK1219421A1 (zh) * | 2013-03-15 | 2017-04-07 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 |
| EP3256126B1 (en) | 2015-02-09 | 2024-03-27 | F. Hoffmann-La Roche AG | Compounds for the treatment of cancer |
| MA41898A (fr) * | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| WO2017050865A1 (en) * | 2015-09-23 | 2017-03-30 | Janssen Pharmaceutica Nv | Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| CA3119019C (en) | 2015-12-10 | 2024-06-11 | Ptc Therapeutics, Inc. | Compounds and methods for treating huntington's disease |
| RS63116B1 (sr) * | 2016-05-06 | 2022-05-31 | Shanghai De Novo Pharmatech Co Ltd | Derivat benzazepina, postupak za dobijanje, farmaceutska kompozicija i njegova upotreba |
| US10913730B2 (en) * | 2016-10-10 | 2021-02-09 | Dong-A Socio Holdings Co., Ltd. | Heteroaryl compounds and their use as Mer inhibitors |
| JP2019535789A (ja) | 2016-11-28 | 2019-12-12 | ピーティーシー セラピューティクス,インコーポレーテッド | Rnaスプライシングを調節する方法 |
| US11590167B2 (en) * | 2016-12-03 | 2023-02-28 | Juno Therapeutic, Inc. | Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors |
| WO2018133865A1 (zh) * | 2017-01-22 | 2018-07-26 | 福建广生堂药业股份有限公司 | Ask1抑制剂及其制备方法和应用 |
| CN108658990B (zh) * | 2017-03-31 | 2021-03-23 | 南京科技职业学院 | 一类新型咪唑并[1,5-a]吡嗪类布鲁顿激酶抑制剂 |
| CN111372611A (zh) | 2017-06-14 | 2020-07-03 | Ptc医疗公司 | 修饰rna剪接的方法 |
| MX2020001425A (es) | 2017-08-04 | 2020-08-06 | Skyhawk Therapeutics Inc | Metodos y composiciones para modular el empalme. |
| US20230152257A1 (en) | 2017-09-25 | 2023-05-18 | Skyhawk Therapeutics, Inc. | Methods and compositions for screening and identification of splicing |
| CN109721597B (zh) * | 2017-10-30 | 2021-05-14 | 上海迪诺医药科技有限公司 | 吡啶并氮杂卓衍生物、其药物组合物及应用 |
| WO2019094312A1 (en) * | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2019105886A1 (en) * | 2017-12-02 | 2019-06-06 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| JP2021521200A (ja) | 2018-04-10 | 2021-08-26 | スカイホーク・セラピューティクス・インコーポレーテッド | 癌の処置のための化合物 |
| WO2020004594A1 (ja) * | 2018-06-27 | 2020-01-02 | 株式会社リボルナバイオサイエンス | 脊髄性筋萎縮症の予防または治療剤 |
| KR20230024328A (ko) * | 2020-06-12 | 2023-02-20 | 상하이 제민케어 파마슈티칼스 컴퍼니 리미티드 | 프탈라지논 화합물, 이의 제조 방법 및 이의 의학적 용도 |
-
2021
- 2021-04-08 CA CA3174353A patent/CA3174353A1/en active Pending
- 2021-04-08 BR BR112022020423A patent/BR112022020423A2/pt unknown
- 2021-04-08 KR KR1020227038394A patent/KR20220167298A/ko active Pending
- 2021-04-08 JP JP2022561080A patent/JP7879597B2/ja active Active
- 2021-04-08 AU AU2021253587A patent/AU2021253587A1/en active Pending
- 2021-04-08 CR CR20220566A patent/CR20220566A/es unknown
- 2021-04-08 WO PCT/US2021/026481 patent/WO2021207554A1/en not_active Ceased
- 2021-04-08 US US17/917,734 patent/US20230167093A1/en active Pending
- 2021-04-08 WO PCT/US2021/026437 patent/WO2021207532A1/en not_active Ceased
- 2021-04-08 TW TW110112826A patent/TWI912305B/zh active
- 2021-04-08 MX MX2022012678A patent/MX2022012678A/es unknown
- 2021-04-08 IL IL297137A patent/IL297137A/en unknown
- 2021-04-08 CN CN202180027107.3A patent/CN115551593A/zh active Pending
- 2021-04-08 EP EP21722078.9A patent/EP4132646A1/en active Pending
- 2021-04-08 US US17/917,729 patent/US20230159496A1/en active Pending
-
2022
- 2022-10-07 CL CL2022002780A patent/CL2022002780A1/es unknown
- 2022-11-04 CO CONC2022/0015925A patent/CO2022015925A2/es unknown